LOCALLY ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Clinical trials for LOCALLY ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy gives hope to elderly esophageal cancer patients
Disease control Recruiting nowThis study tests whether adding the immunotherapy drug iparomlimab after standard chemoradiation can help older adults (70+) with inoperable esophageal cancer live longer without the disease getting worse. About 52 participants will receive the drug for one year after chemoradiat…
Matched conditions: LOCALLY ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Can a drug combo turn inoperable esophageal cancer into a surgical target?
Disease control Recruiting nowThis study tests whether a combination of tislelizumab (an immunotherapy) and chemotherapy can shrink advanced esophageal tumors enough to allow surgery. Thirty patients with initially inoperable cancer will receive 2-4 cycles of the drug combo, then be reassessed for surgery. Th…
Matched conditions: LOCALLY ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Sponsor: Shandong Provincial Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New combo therapy aims to boost survival in esophageal cancer patients
Disease control Recruiting nowThis study tests whether adding immunotherapy to a precise type of radiotherapy (sparing tumor-draining lymph nodes) and chemotherapy can help adults with advanced esophageal cancer live longer without the disease getting worse. About 432 participants will receive either the comb…
Matched conditions: LOCALLY ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE3 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC